Registration statement for securities of certain foreign private issuers

Revenue

v3.21.2
Revenue
6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Text block [abstract]    
Revenue
5.
Revenue
i) Disaggregation of revenue
 
    
For the Six Months Ended June 30,
 
    
2021
    
2020
 
    
$’000
    
$’000
 
Clinical services
     18,134        12,149  
Software licensing
     44,245        10,354  
Value based care
     66,392        —    
    
 
 
    
 
 
 
    
 
128,771
 
  
 
22,503
 
    
 
 
    
 
 
 
In January 2021, we entered into a License and Support Agreement (“License Agreement”) with TELUS. As part of the License Agreement, the Group received an upfront payment of approximately $66.9 million in exchange for the right to use the Company’s digital healthcare platform (“Software Platform”), specified upgrades to be delivered over a 24-month period, post-contract support (“PCS”), and a right to access enhancements to the Group’s Software Platform over a period of seven years. We identified that the License Agreement included multiple performance obligations and allocated the transaction price to the separate performance obligations on a relative standalone basis. We determined the standalone selling prices based on our overall pricing objectives, taking into consideration market inputs and entity specific factors, including standalone selling prices when available. We also concluded that the upfront payment included a significant financing component. As a result, the transaction price was adjusted to account for the time value of money and interest expense will be recognized over the duration of the contract.
ii) Contract balances
The following table provides information about receivables, contract assets and contract liabilities from contracts with customers.
 
    
June 30,
2021
    
December 31,
2020
 
    
$’000
    
$’000
 
Trade receivables
     10,951        4,674  
Contract assets
     2,491        2,378  
Contract liabilities
     (105,118      (76,018
The contract assets primarily relate to the Group’s rights to consideration for work completed but not billed at the reporting date. There was no impact on contract assets as a result of acquisition of subsidiaries. The contract assets are transferred to receivables when the rights become unconditional. This usually occurs when the Group issues an invoice to the customer. The Group’s customers generally pay for invoices in the month following the issuance date.
iii) Transaction price allocated to the remaining performance obligations
The following table includes revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the reporting date.
 
    
Remainder
of 2021
    
2022
    
2023
    
2024
    
2025
and
beyond
    
Total
 
    
$’000
    
$’000
    
$’000
    
$’000
    
$’000
    
$’000
 
At June 30, 2021
     13,317        19,791        19,246        19,833        32,931        105,118  
The table below shows significant changes in contract liabilities:
 
    
2021
 
    
$’000
 
Balance on January 1
     76,018  
Amounts billed but not recognized
     70,728  
Revenue recognized
     (41,628
    
 
 
 
Balance on June 30
  
 
105,118
 
    
 
 
 
6.
Revenue
i) Disaggregation of revenue
 
    
2020
    
2019
 
    
$’000
    
$’000
 
Clinical services
     28,631        14,032  
Software licensing revenue
     24,603        2,002  
Value based care
     26,038        —    
    
 
 
    
 
 
 
    
 
79,272
 
  
 
16,034
 
    
 
 
    
 
 
 
ii) Contract balances
The following table provides information about receivables, contract assets and contract liabilities from contracts with customers.
 
    
2020
    
2019
 
    
$’000
    
$’000
 
Trade receivables (Note 17)
     4,674        3,016  
Contract assets (Note 17)
     2,378        1,541  
Contract liabilities (Note 6 iii)
     76,018        81,584  
The contract assets primarily relate to the Group’s rights to consideration for work completed but not billed at the reporting date. There was no impact on contract assets as a result of acquisition of subsidiaries. The contract assets are transferred to receivables when the rights become unconditional. This usually occurs when the Group issues an invoice to the customer. The Group’s customers generally pay for invoices in the month following the issuance date.
iii) Transaction price allocated to the remaining performance obligations
The following table includes revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the reporting date.
 
    
2020
    
2021
    
2022
    
2023
    
2024
and
beyond
    
Total
 
    
$’000
    
$’000
    
$’000
    
$’000
    
$’000
    
$’000
 
At December 31, 2020
     —          18,744        13,883        14,174        29,217        76,018  
At December 31, 2019
     16,690        26,755        24,027        14,112        —          81,584  
The table below shows significant changes in contract liabilities:
 
    
2020
    
2019
 
    
$’000
    
$’000
 
Balance on January 1
     81,584        82,542  
Amounts billed but not recognized
     18,080        1,808  
Revenue recognized
     (23,646      (2,766
    
 
 
    
 
 
 
Balance on December 31
  
 
76,018
 
  
 
81,584